West Pharmaceutical Services | WST - Capital Ordinário





Capital Ordinário Alterar Data
Align Technology USD 71.62M 133K 2026-03
Avanos Medical USD 46.67M 216.61K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cooper Companies USD 195.11M 14K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Haemonetics USD 46.83M 82K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Neogen USD 217.67M 147K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quidel USD 67.9M 0 2025-12
Repligen USD 56.4M 74K 2026-03
Solventum Corp USD 173.53M 40.79K 2026-03
STAAR Surgical USD 49.78M 377K 2026-03
Terumo JPY 1.48B 11K 2026-03
Utah Medical Products USD 3.19M 3.15M 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03